--Lonza has chosen U.S. investment banks Bank of America and Centerview Partners to oversee the sale of its capsules business, as the Swiss drug manufacturer attempts to streamline its business, Bloomberg Law reported, citing unnamed sources.
--The deal could be worth at least 2.5 billion euros ($2.62 billion) but details of the transaction could still change, according to one source, the report said.
Full story: https://bit.ly/40XJe9g
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
February 18, 2025 07:07 ET (12:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.